UBE2C and breast carcinoma: In Figures 5A, B, it revealed that the mRNA levels of UBE2S and UBE2C were lower in breast cancer patients who had a longer lifespan than those with a shorter lifespan, grouped by overall survival status or survival status at 5 years (alive or dead).